LSM14A and neoplasm: We also found that tumors with higher expression of LSM12, LSM14A, and LSM14B had higher expression of tumor-related immune checkpoints (e.g., PD-L1, B7-H3, and PVR), which are important for the immunosuppressive phenotype in malignancies (Figures 8A–C) (20–24).